View Clinical Trial (Medical Research Study)
Rapamycin as Treatment for ADPKD: The Role of Biomarkers in Predicting a Response to Therapy
| City: |
|
New Haven |
| State: |
|
Connecticut |
| Zip Code: |
|
06520 |
| Conditions: |
|
Autosomal Dominant Polycystic Kidney Disease |
| Purpose: |
|
Currently the only approved use for rapamycin (sirolimus) is for immunosuppression after
renal transplantation.
This trial is designed to determine whether rapamycin is safe and effective treatment for
patients with polycystic kidney disease (ADPKD). Patients will be followed by volumetric
magnetic resonance imaging (MRI) to observe for change in kidney (and cyst) size. Blood and
urine samples will also be collected to evaluate for change in biomarkers with treatment.
|
| Study Summary: |
|
This is a 2 year, open label trial to evaluate the role of rapamycin as treatment for ADPKD.
Patients will be randomized 2:1 to the rapamycin arm or to standard therapy. The dose of
rapamycin will be adjusted so that patients obtain 24 trough levels of 4-6ng/ml. There will
be a volumetric MRI measurement at the start and end of the treatment period. Patients will
be monitored every 4 months throughout the study.
|
| Criteria: |
|
Inclusion Criteria:
- adult ADPKD patients aged 18-70
- combined kidney volume >1200 ml
- estimated creatinine clearance >60 ml/min
- absence of implanted ferromagnetic objects
Exclusion Criteria:
- Age >70
- uncontrolled hyperlipidemia
- Proteinuria >500 mg/day
- unstable cerebral aneurysm
- active coronary artery disease
- diagnosis of another systemic condition affecting kidney function (ie: diabetes,
hepatitis B or C, HIV)
- diagnosis of cancer other than skin cancer
- pregnancy or lactation
- presence of implanted ferromagnetic objects
|
| NCT ID: |
|
NCT00920309 |
| Primary Contact: |
|
Principal Investigator
Neera K Dahl, MD, PhD
Yale University
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
New Haven, Connecticut 06520
United States
Neera K Dahl, MD, PhD
Phone: 203-785-4184
Email: neera.dahl@yale.edu
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 25, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|